AngioDynamics, Inc. (ANGO)
USD 9.0
(-3.33%)
USD 9.0
(-3.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 60.61 Million USD | 9.56% |
| 2023 | 55.32 Million USD | 7.65% |
| 2022 | 51.39 Million USD | 5.71% |
| 2021 | 48.61 Million USD | -18.85% |
| 2020 | 59.9 Million USD | 49.5% |
| 2019 | 40.07 Million USD | -18.08% |
| 2018 | 48.91 Million USD | -10.26% |
| 2017 | 54.5 Million USD | -1.56% |
| 2016 | 55.37 Million USD | -17.83% |
| 2015 | 67.38 Million USD | 10.37% |
| 2014 | 61.05 Million USD | 10.89% |
| 2013 | 55.06 Million USD | -1.36% |
| 2012 | 55.82 Million USD | 98.93% |
| 2011 | 28.06 Million USD | -3.95% |
| 2010 | 29.21 Million USD | -20.88% |
| 2009 | 36.92 Million USD | 61.25% |
| 2008 | 22.9 Million USD | -19.84% |
| 2007 | 28.56 Million USD | 78.91% |
| 2006 | 15.96 Million USD | 55.57% |
| 2005 | 10.26 Million USD | 20.12% |
| 2004 | 8.54 Million USD | -1.0% |
| 2003 | 8.63 Million USD | 9.13% |
| 2002 | 7.9 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 59.97 Million USD | 8.4% |
| 2024 FY | 60.61 Million USD | 9.56% |
| 2024 Q3 | 58.06 Million USD | -9.63% |
| 2024 Q2 | 64.25 Million USD | 7.14% |
| 2024 Q4 | 60.61 Million USD | 4.39% |
| 2023 Q4 | 55.32 Million USD | -12.92% |
| 2023 Q3 | 63.53 Million USD | 0.56% |
| 2023 Q2 | 63.17 Million USD | 9.67% |
| 2023 Q1 | 57.6 Million USD | 12.1% |
| 2023 FY | 55.32 Million USD | 7.65% |
| 2022 Q1 | 49.3 Million USD | 1.42% |
| 2022 FY | 51.39 Million USD | 5.71% |
| 2022 Q2 | 48.18 Million USD | -2.28% |
| 2022 Q4 | 51.39 Million USD | 6.98% |
| 2022 Q3 | 48.03 Million USD | -0.3% |
| 2021 Q1 | 52.76 Million USD | -11.92% |
| 2021 Q4 | 48.61 Million USD | -0.8% |
| 2021 Q2 | 49.58 Million USD | -6.03% |
| 2021 Q3 | 49 Million USD | -1.16% |
| 2021 FY | 48.61 Million USD | -18.85% |
| 2020 FY | 59.9 Million USD | 49.5% |
| 2020 Q2 | 50.23 Million USD | 11.08% |
| 2020 Q3 | 54.89 Million USD | 9.27% |
| 2020 Q4 | 59.9 Million USD | 9.12% |
| 2020 Q1 | 45.22 Million USD | 12.87% |
| 2019 Q2 | 50.63 Million USD | 1.84% |
| 2019 Q1 | 49.72 Million USD | 1.65% |
| 2019 FY | 40.07 Million USD | -18.08% |
| 2019 Q3 | 52.38 Million USD | 3.46% |
| 2019 Q4 | 40.07 Million USD | -23.51% |
| 2018 FY | 48.91 Million USD | -10.26% |
| 2018 Q1 | 55.42 Million USD | 1.69% |
| 2018 Q2 | 54.03 Million USD | -2.51% |
| 2018 Q3 | 56.56 Million USD | 4.69% |
| 2018 Q4 | 48.91 Million USD | -13.52% |
| 2017 Q3 | 57.68 Million USD | 1.79% |
| 2017 FY | 54.5 Million USD | -1.56% |
| 2017 Q4 | 54.5 Million USD | -5.5% |
| 2017 Q2 | 56.66 Million USD | -2.76% |
| 2017 Q1 | 58.27 Million USD | 5.24% |
| 2016 Q3 | 65.79 Million USD | -7.09% |
| 2016 Q4 | 55.37 Million USD | -15.84% |
| 2016 Q1 | 74.32 Million USD | 10.3% |
| 2016 FY | 55.37 Million USD | -17.83% |
| 2016 Q2 | 70.81 Million USD | -4.73% |
| 2015 FY | 67.38 Million USD | 10.37% |
| 2015 Q4 | 67.38 Million USD | -1.92% |
| 2015 Q3 | 68.71 Million USD | -8.77% |
| 2015 Q2 | 75.31 Million USD | 6.96% |
| 2015 Q1 | 70.41 Million USD | 15.33% |
| 2014 Q2 | 60.05 Million USD | 1.36% |
| 2014 FY | 61.05 Million USD | 10.89% |
| 2014 Q3 | 59.83 Million USD | -0.36% |
| 2014 Q4 | 61.05 Million USD | 2.04% |
| 2014 Q1 | 59.24 Million USD | 7.6% |
| 2013 FY | 55.06 Million USD | -1.36% |
| 2013 Q4 | 55.06 Million USD | -11.15% |
| 2013 Q2 | 62.33 Million USD | -1.71% |
| 2013 Q1 | 63.41 Million USD | 13.6% |
| 2013 Q3 | 61.97 Million USD | -0.57% |
| 2012 Q1 | 29.67 Million USD | 5.74% |
| 2012 Q2 | 29.42 Million USD | -0.83% |
| 2012 Q3 | 28.15 Million USD | -4.31% |
| 2012 Q4 | 55.82 Million USD | 98.25% |
| 2012 FY | 55.82 Million USD | 98.93% |
| 2011 Q3 | 29.48 Million USD | -9.9% |
| 2011 Q1 | 33.51 Million USD | 14.72% |
| 2011 FY | 28.06 Million USD | -3.95% |
| 2011 Q4 | 28.06 Million USD | -4.84% |
| 2011 Q2 | 32.73 Million USD | -2.35% |
| 2010 Q3 | 34.11 Million USD | -14.44% |
| 2010 Q4 | 29.21 Million USD | -14.36% |
| 2010 FY | 29.21 Million USD | -20.88% |
| 2010 Q2 | 39.87 Million USD | -10.08% |
| 2010 Q1 | 44.34 Million USD | 20.08% |
| 2009 Q3 | 32.41 Million USD | 13.4% |
| 2009 Q4 | 36.92 Million USD | 13.92% |
| 2009 FY | 36.92 Million USD | 61.25% |
| 2009 Q2 | 28.58 Million USD | 1.37% |
| 2009 Q1 | 28.19 Million USD | 23.13% |
| 2008 Q2 | 27.52 Million USD | -10.49% |
| 2008 Q4 | 22.9 Million USD | -9.57% |
| 2008 Q3 | 25.32 Million USD | -8.0% |
| 2008 FY | 22.9 Million USD | -19.84% |
| 2008 Q1 | 30.75 Million USD | 7.65% |
| 2007 Q1 | 18.42 Million USD | 15.36% |
| 2007 Q4 | 28.56 Million USD | 4.54% |
| 2007 Q3 | 27.32 Million USD | 46.24% |
| 2007 Q2 | 18.68 Million USD | 1.44% |
| 2007 FY | 28.56 Million USD | 78.91% |
| 2006 Q4 | 15.96 Million USD | 21.55% |
| 2006 Q2 | 10.7 Million USD | -2.66% |
| 2006 Q1 | 10.99 Million USD | 7.15% |
| 2006 FY | 15.96 Million USD | 55.57% |
| 2006 Q3 | 13.13 Million USD | 22.72% |
| 2005 Q3 | 9.38 Million USD | 3.79% |
| 2005 Q1 | 9.21 Million USD | 7.85% |
| 2005 Q2 | 9.04 Million USD | -1.86% |
| 2005 FY | 10.26 Million USD | 20.12% |
| 2005 Q4 | 10.26 Million USD | 9.33% |
| 2004 Q4 | 8.54 Million USD | -4.91% |
| 2004 Q3 | 8.98 Million USD | 0.0% |
| 2004 FY | 8.54 Million USD | -1.0% |
| 2003 FY | 8.63 Million USD | 9.13% |
| 2003 Q4 | 8.63 Million USD | 0.0% |
| 2002 FY | 7.9 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -239.073% |
| AtriCure, Inc. | 67.89 Million USD | 10.724% |
| Avinger, Inc. | 5.29 Million USD | -1044.13% |
| Azenta, Inc. | 128.19 Million USD | 52.717% |
| BioLife Solutions, Inc. | 43.45 Million USD | -39.488% |
| The Cooper Companies, Inc. | 735.6 Million USD | 91.76% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -1100.317% |
| Femasys Inc. | 667.11 Thousand USD | -8986.249% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -145.25% |
| Hologic, Inc. | 679.8 Million USD | 91.083% |
| ICU Medical, Inc. | 709.36 Million USD | 91.455% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 95.034% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -1641.188% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -15.827% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -6975.035% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -6975.035% |
| Masimo Corporation | 545 Million USD | 88.878% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -3648.149% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 80.052% |
| Nephros, Inc. | 2.47 Million USD | -2354.089% |
| NovoCure Limited | 38.15 Million USD | -58.88% |
| NEXGEL, Inc. | 1.31 Million USD | -4495.603% |
| NEXGEL, Inc. | 1.31 Million USD | -4495.603% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -346.625% |
| OraSure Technologies, Inc. | 47.61 Million USD | -27.307% |
| Pro-Dex, Inc. | 15.26 Million USD | -296.987% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -12161.163% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -2013.455% |
| QuidelOrtho Corporation | 577.8 Million USD | 89.509% |
| Repligen Corporation | 202.32 Million USD | 70.04% |
| Sanara MedTech Inc. | 4.71 Million USD | -1184.909% |
| STAAR Surgical Company | 35.13 Million USD | -72.548% |
| Sharps Technology, Inc. | 1.7 Million USD | -3446.589% |
| Utah Medical Products, Inc. | 9.58 Million USD | -532.603% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 90.286% |
| Jin Medical International Ltd. | 5.05 Million USD | -1099.572% |